BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 16860853)

  • 1. Clinicopathologic features of early adenocarcinoma of the cervix initially managed with cervical conization.
    Poynor EA; Marshall D; Sonoda Y; Slomovitz BM; Barakat RR; Soslow RA
    Gynecol Oncol; 2006 Dec; 103(3):960-5. PubMed ID: 16860853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conservative treatment of stage IA1 adenocarcinoma of the cervix during pregnancy.
    Yahata T; Numata M; Kashima K; Sekine M; Fujita K; Yamamoto T; Tanaka K
    Gynecol Oncol; 2008 Apr; 109(1):49-52. PubMed ID: 18289649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
    Poynor EA; Barakat RR; Hoskins WJ
    Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenocarcinoma in situ of the cervix: management and outcome.
    Azodi M; Chambers SK; Rutherford TJ; Kohorn EI; Schwartz PE; Chambers JT
    Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early invasive carcinoma of the cervix.
    Jones WB; Mercer GO; Lewis JL; Rubin SC; Hoskins WJ
    Gynecol Oncol; 1993 Oct; 51(1):26-32. PubMed ID: 8244170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
    Denehy TR; Gregori CA; Breen JL
    Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenocarcinoma in situ of the uterine cervix.
    Muntz HG; Bell DA; Lage JM; Goff BA; Feldman S; Rice LW
    Obstet Gynecol; 1992 Dec; 80(6):935-9. PubMed ID: 1448263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early invasive adenocarcinoma of the uterine cervix: criteria for nonradical surgical treatment.
    Kasamatsu T; Okada S; Tsuda H; Shiromizu K; Yamada T; Tsunematsu R; Ohmi K
    Gynecol Oncol; 2002 May; 85(2):327-32. PubMed ID: 11972396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conservative management of adenocarcinoma in situ of the cervix.
    Shin CH; Schorge JO; Lee KR; Sheets EE
    Gynecol Oncol; 2000 Oct; 79(1):6-10. PubMed ID: 11006022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of outcomes of microinvasive adenocarcinoma of the uterine cervix by treatment type.
    Reynolds EA; Tierney K; Keeney GL; Felix JC; Weaver AL; Roman LD; Cliby WA
    Obstet Gynecol; 2010 Nov; 116(5):1150-7. PubMed ID: 20966701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of residual neoplasia based on histopathology and margin status of conization specimens.
    Chang DY; Cheng WF; Torng PL; Chen RJ; Huang SC
    Gynecol Oncol; 1996 Oct; 63(1):53-6. PubMed ID: 8898168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease.
    Im DD; Duska LR; Rosenshein NB
    Gynecol Oncol; 1995 Nov; 59(2):179-82. PubMed ID: 7590468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fertility-sparing surgery in 101 women with adenocarcinoma in situ of the cervix.
    Bull-Phelps SL; Garner EI; Walsh CS; Gehrig PA; Miller DS; Schorge JO
    Gynecol Oncol; 2007 Nov; 107(2):316-9. PubMed ID: 17689593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective management of stage IA(1) cervical adenocarcinoma by conization alone to preserve fertility: a preliminary report.
    Schorge JO; Lee KR; Sheets EE
    Gynecol Oncol; 2000 Aug; 78(2):217-20. PubMed ID: 10926806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical adenocarcinoma in situ: the predictive value of conization margin status.
    Young JL; Jazaeri AA; Lachance JA; Stoler MH; Irvin WP; Rice LW; Andersen WA; Modesitt SC
    Am J Obstet Gynecol; 2007 Aug; 197(2):195.e1-7; discussion 195.e7-8. PubMed ID: 17689647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of microinvasive adenocarcinoma of the uterine cervix: a retrospective study and review of the literature.
    Bisseling KC; Bekkers RL; Rome RM; Quinn MA
    Gynecol Oncol; 2007 Dec; 107(3):424-30. PubMed ID: 17707895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk for residual adenocarcinoma in situ or cervical adenocarcinoma in women undergoing loop electrosurgical excision procedure/conization for adenocarcinoma in situ.
    DeSimone CP; Day ME; Dietrich CS; Tovar MM; Modesitt SC
    J Reprod Med; 2011; 56(9-10):376-80. PubMed ID: 22010519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical conization as definitive therapy for early invasive squamous carcinoma of the cervix.
    Morris M; Mitchell MF; Silva EG; Copeland LJ; Gershenson DM
    Gynecol Oncol; 1993 Nov; 51(2):193-6. PubMed ID: 8276293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenocarcinoma in situ of the uterine cervix: management and outcome.
    Widrich T; Kennedy AW; Myers TM; Hart WR; Wirth S
    Gynecol Oncol; 1996 Jun; 61(3):304-8. PubMed ID: 8641606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microinvasive carcinoma of the cervix.
    Leman MH; Benson WL; Kurman RJ; Park RC
    Obstet Gynecol; 1976 Nov; 48(5):571-8. PubMed ID: 980284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.